Amgen Discloses Breach of Proprietary Information and Patient Data in Cloud Environment
Amgen disclosed in a filing with the U.S. Securities and Exchange Commission that proprietary information and patient data were compromised in its cloud environment. As of July 29, 2026, the company determined that the cybersecurity incident was material. Amgen expects the incident will not have a material impact on its financial condition or operating results. The investigation remains ongoing.
Amgen disclosed in a filing with the U.S. Securities and Exchange Commission that proprietary information and patient data were compromised in its cloud environment.
As of July 29, 2026, the company determined that the cybersecurity incident was material. Amgen expects the incident will not have a material impact on its financial condition or operating results.
The investigation remains ongoing.
As of July 29, 2026, the company determined that the cybersecurity incident was material. Amgen expects the incident will not have a material impact on its financial condition or operating results.
The investigation remains ongoing.